Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-000883191 in Rheumatoid Arthritis
2004-004302-24Phase 2Completed
- Sponsor
- MSD Finland
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing L-000883191 arm with Placebo arm (2 arms). Primary endpoint: Swollen joint count response. Started Nov 2004; status: completed.
02
Drugs
mk-0812
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-004302-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004302-24.